BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35953984)

  • 1. Andrographolide and Deoxyandrographolide Inhibit Protease and IFN-Antagonist Activities of Foot-and-Mouth Disease Virus 3C
    Theerawatanasirikul S; Lueangaramkul V; Thangthamniyom N; Chankeeree P; Semkum P; Lekcharoensuk P
    Animals (Basel); 2022 Aug; 12(15):. PubMed ID: 35953984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Molecules Targeting 3C Protease Inhibit FMDV Replication and Exhibit Virucidal Effect in Cell-Based Assays.
    Theerawatanasirikul S; Lueangaramkul V; Pantanam A; Mana N; Semkum P; Lekcharoensuk P
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent small molecule inhibitors against the 3C protease of foot-and-mouth disease virus.
    Kim Y; Pool E; Kim E; Dampalla CS; Nguyen HN; Johnson DK; Lovell S; Groutas WC; Chang K-O
    Microbiol Spectr; 2024 Apr; 12(4):e0337223. PubMed ID: 38466127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Phytochemicals, Luteolin and Isoginkgetin, Inhibit 3C Protease and Infection of FMDV, In Silico and In Vitro.
    Theerawatanasirikul S; Thangthamniyom N; Kuo CJ; Semkum P; Phecharat N; Chankeeree P; Lekcharoensuk P
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation.
    Du Y; Bi J; Liu J; Liu X; Wu X; Jiang P; Yoo D; Zhang Y; Wu J; Wan R; Zhao X; Guo L; Sun W; Cong X; Chen L; Wang J
    J Virol; 2014 May; 88(9):4908-20. PubMed ID: 24554650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foot-and-Mouth Disease Virus 3C Protease Antagonizes Interferon Signaling and C142T Substitution Attenuates the FMD Virus.
    Ekanayaka P; Shin SH; Weeratunga P; Lee H; Kim TH; Chathuranga K; Subasinghe A; Park JH; Lee JS
    Front Microbiol; 2021; 12():737031. PubMed ID: 34867853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral mechanisms of sorafenib against foot-and-mouth disease virus via c-RAF and AKT/PI3K pathways.
    Theerawatanasirikul S; Lueangaramkul V; Semkum P; Lekcharoensuk P
    Vet Res Commun; 2024 Feb; 48(1):329-343. PubMed ID: 37697209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foot-and-Mouth Disease Virus Induces Porcine Gasdermin E-Mediated Pyroptosis through the Protease Activity of 3C
    Ren X; Yin M; Zhao Q; Zheng Z; Wang H; Lu Z; Li X; Qian P
    J Virol; 2023 Jul; 97(7):e0068623. PubMed ID: 37367489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
    Steigerwald R; Brake DA; Barrera J; Schutta CJ; Kalla M; Wennier ST; Volkmann A; Hurtle W; Clark BA; Zurita M; Pisano M; Kamicker BJ; Puckette MC; Rasmussen MV; Neilan JG
    Vaccine; 2020 Jan; 38(4):769-778. PubMed ID: 31718901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-Site SUMOylation of FMDV 3C Protease and Its Negative Role in Viral Replication.
    Wu X; Hu Y; Sui C; Pan L; Yoo D; Miller LC; Lee C; Cong X; Li J; Du Y; Qi J
    J Virol; 2022 Sep; 96(17):e0061222. PubMed ID: 36005757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Nucleoside Inhibitors Decrease Foot-and-Mouth Disease Virus Replication by Blocking the Viral 3D
    Theerawatanasirikul S; Semkum P; Lueangaramkul V; Chankeeree P; Thangthamniyom N; Lekcharoensuk P
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development.
    Puckette M; Clark BA; Smith JD; Turecek T; Martel E; Gabbert L; Pisano M; Hurtle W; Pacheco JM; Barrera J; Neilan JG; Rasmussen M
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foot-and-Mouth Disease Virus 3C
    Ekanayaka P; Weerawardhana A; Chathuranga K; Park JH; Lee JS
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling.
    Wang D; Fang L; Li K; Zhong H; Fan J; Ouyang C; Zhang H; Duan E; Luo R; Zhang Z; Liu X; Chen H; Xiao S
    J Virol; 2012 Sep; 86(17):9311-22. PubMed ID: 22718831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foot-and-Mouth Disease Virus Leader Protease Cleaves G3BP1 and G3BP2 and Inhibits Stress Granule Formation.
    Visser LJ; Medina GN; Rabouw HH; de Groot RJ; Langereis MA; de Los Santos T; van Kuppeveld FJM
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression.
    Liu H; Zhu Z; Xue Q; Yang F; Cao W; Zhang K; Liu X; Zheng H
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Antiviral Innate Immunity by Foot-and-Mouth Disease Virus L
    Sui C; Jiang D; Wu X; Liu S; Li F; Pan L; Cong X; Li J; Yoo D; Rock DL; Miller LC; Lee C; Du Y; Qi J
    J Virol; 2021 Jul; 95(15):e0036121. PubMed ID: 33980594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3C
    Wu X; Chen L; Sui C; Hu Y; Jiang D; Yang F; Miller LC; Li J; Cong X; Hrabchenko N; Lee C; Du Y; Qi J
    Virol Sin; 2023 Jun; 38(3):387-397. PubMed ID: 36921803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot-and-Mouth Disease Virus Evades Innate Immune Response by 3C-Targeting of MDA5.
    Kim H; Kim AY; Choi J; Park SY; Park SH; Kim JS; Lee SI; Park JH; Park CK; Ko YJ
    Cells; 2021 Jan; 10(2):. PubMed ID: 33572945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foot-and-Mouth Disease Virus Counteracts on Internal Ribosome Entry Site Suppression by G3BP1 and Inhibits G3BP1-Mediated Stress Granule Assembly
    Ye X; Pan T; Wang D; Fang L; Ma J; Zhu X; Shi Y; Zhang K; Zheng H; Chen H; Li K; Xiao S
    Front Immunol; 2018; 9():1142. PubMed ID: 29887867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.